The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry

Uwe Zeymer1, Peter Ludman2, Nicolas Danchin3

  • 1Hospital of the City of Ludwigshafen, Medical Clinic B and Institute of Heart Attack Research, Ludwigshafen on the Rhine, Germany.

Insights

This study assessed reperfusion therapy use and guideline adherence in ST-elevation myocardial infarction (STEMI) patients across Europe. Findings offer insights into current STEMI care and outcomes.

Area of Science:

  • Cardiology
  • Clinical Research
  • Public Health

Background:

  • The European Society of Cardiology (ESC) provides guidelines for ST-elevation myocardial infarction (STEMI) management.
  • Reperfusion therapy is crucial for STEMI patients, aiming to restore blood flow to the heart muscle.
  • Understanding current practices and guideline adherence is essential for improving STEMI care.

Purpose of the Study:

  • To evaluate the current use of reperfusion therapy in STEMI patients within ESC member and affiliated countries.
  • To assess adherence to ESC STEMI guidelines regarding reperfusion and adjunctive treatments.
  • To describe demographic, clinical, and angiographic characteristics of STEMI patients and their 1-year outcomes.

Main Methods:

  • The study enrolled 11,462 STEMI patients from 196 centers across 29 countries between January 2015 and March 2018.
  • Data collection included patient demographics, clinical presentation, angiographic findings, and treatment strategies.
  • A 1-year follow-up was planned to assess patient outcomes.

Main Results:

  • The registry captured data on 11,462 STEMI patients, providing a comprehensive overview of contemporary STEMI care.
  • Analysis focused on reperfusion strategies, adjunctive therapies, and adherence to 2012 ESC STEMI guidelines.
  • The study aimed to correlate treatment patterns with patient outcomes over a 1-year period.

Conclusions:

  • The ESC ACCA-EAPCI EORP ACS STEMI registry offers valuable insights into STEMI patient profiles and management.
  • It highlights current reperfusion therapy use and guideline adherence in clinical practice.
  • The registry will elucidate the impact of contemporary management on 1-year outcomes for STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
868
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
283
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
372
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
222
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
230
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
39.6K